Insider Trades22 trades
| Date↓ | Side | Ticker↕ | Insider↕ | Role↕ | Shares↕ | Price↕ | Mkt Cap↕ | 52W High↕ | 52W Low↕ | Value↕ | % Chg↕ | Rule↕ | AI View↕ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Aug 7, 2026 | Sell | SHC | Michael P Rutz | President of Sterigenics | 150,000 | $18.84 | $5.5B | -2.92% | +47.21% | $2.8M | -30.97% | — | — |
| Aug 5, 2026 | Sell | SHC | Jonathan M. Lyons | Sr. Vice President, CFO | 11,316 | $17.98 | $5.5B | -2.92% | +47.21% | $203.5K | -2.93% | — | — |
| Mar 31, 2026 | Sell | SHC | Alexander Dimitrief | Former SVP, GC and Sec. | 7,941 | $14.34 | $5.5B | -2.92% | +47.21% | $113.9K | -2.48% | — | — |
| Mar 2, 2026 | Sell | SHC | Michael P Rutz | President of Sterigenics | 25,721 | $15.91 | $5.5B | -2.92% | +47.21% | $409.2K | -1.86% | — | — |
| Mar 2, 2026 | Sell | SHC | Alexander Dimitrief | SVP, General Counsel and Sec. | 31,560 | $15.91 | $5.5B | -2.92% | +47.21% | $502.1K | -4.58% | — | — |
| Mar 2, 2026 | Sell | SHC | Jonathan M. Lyons | Sr. Vice President, CFO | 38,274 | $15.91 | $5.5B | -2.92% | +47.21% | $608.9K | -6.27% | — | — |
| Mar 2, 2026 | Sell | SHC | Michael B. Jr. Petras | Chairman & CEO | 190,297 | $15.91 | $5.5B | -2.92% | +47.21% | $3.0M | -8.08% | — | — |
| Dec 8, 2025 | Sell | SHC | Michael B. Jr. Petras | Chairman & CEO | 750,000 | $16.45 | $5.5B | -2.92% | +47.21% | $12.3M | -12.25% | — | — |
| Aug 22, 2025 | Sell | SHC | Michael P Rutz | President of Sterigenics | 126,611 | $16.38 | $5.5B | -2.92% | +47.21% | $2.1M | -14.09% | — | — |
| Aug 5, 2025 | Sell | SHC | Jonathan M. Lyons | Sr. Vice President, CFO | 11,508 | $11.19 | $5.5B | -2.92% | +47.21% | $128.8K | -3.32% | — | — |
| Mar 2, 2025 | Sell | SHC | Jonathan M. Lyons | Sr. Vice President, CFO | 6,481 | $12.47 | $5.5B | -2.92% | +47.21% | $80.8K | -2.87% | — | — |
| Mar 2, 2025 | Sell | SHC | Alexander Dimitrief | SVP, General Counsel and Sec. | 8,211 | $12.47 | $5.5B | -2.92% | +47.21% | $102.4K | -0.83% | — | — |
| Mar 2, 2025 | Sell | SHC | Michael P Rutz | President of Sterigenics | 13,284 | $12.47 | $5.5B | -2.92% | +47.21% | $165.7K | -0.70% | — | — |
| Mar 2, 2025 | Sell | SHC | Michael B. Jr. Petras | Chairman & CEO | 100,849 | $12.47 | $5.5B | -2.92% | +47.21% | $1.3M | -1.53% | — | — |
| Nov 20, 2024 | Sell | SHC | Michael P Rutz | President of Sterigenics | 2,889 | $13.21 | $5.5B | -2.92% | +47.21% | $38.2K | -0.34% | — | — |
| Nov 20, 2024 | Sell | SHC | Michael B. Jr. Petras | Chairman & CEO | 107,736 | $3.59 | $5.5B | -2.92% | +47.21% | $386.4K | -0.28% | — | — |
| Sep 10, 2024 | Sell | SHC | Michael B. Jr. Petras | Chairman & CEO | 200,000 | $16.13 | $5.5B | -2.92% | +47.21% | $3.2M | -1.98% | — | — |
| Aug 5, 2024 | Sell | SHC | Jonathan M. Lyons | Sr. Vice President, CFO | 7,659 | $14.22 | $5.5B | -2.92% | +47.21% | $108.9K | -3.28% | — | — |
| Mar 2, 2024 | Sell | SHC | Michael P Rutz | President of Sterigenics | 88,610 | $14.32 | $5.5B | -2.92% | +47.21% | $1.3M | -4.32% | — | — |
| Mar 2, 2024 | Sell | SHC | Michael B. Jr. Petras | Chairman & CEO | 1,053,434 | $14.32 | $5.5B | -2.92% | +47.21% | $15.1M | -9.17% | — | — |
| Nov 20, 2023 | Sell | SHC | Michael P Rutz | President of Sterigenics | 1,911 | $13.93 | $5.5B | -2.92% | +47.21% | $26.6K | -0.23% | — | — |
| Nov 20, 2023 | Sell | SHC | Michael B. Jr. Petras | Chairman & CEO | 29,250 | $13.93 | $5.5B | -2.92% | +47.21% | $407.5K | -0.62% | — | — |